Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) (TGF-beta)
Administration of TGF-b Resistant LMP-Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma
Sponsor: Baylor College of Medicine
This PHASE1 trial investigates Hodgkin's Disease and Lymphoma and is currently ongoing. Baylor College of Medicine leads this study, which shows 19 recorded versions since 2006 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
19 versions recorded-
Nov 2025 — Present [monthly]
Active Not Recruiting PHASE1
-
Dec 2024 — Nov 2025 [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
▶ Show 14 earlier versions
-
Jan 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE1
-
Jan 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE1
-
Oct 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE1
-
Mar 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE1
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE1
-
Nov 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE1
-
Nov 2018 — Nov 2019 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE1
-
Nov 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
-
Sep 2017 — Nov 2017 [monthly]
Active Not Recruiting PHASE1
-
Feb 2017 — Sep 2017 [monthly]
Active Not Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Apr 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
- Center for Cell and Gene Therapy, Baylor College of Medicine
- The Methodist Hospital Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .